Research Topics
| K MichaudSummaryAffiliation: University of Nebraska Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Impact of total shoulder arthroplasty on generic and shoulder-specific health-related quality-of-life measures: a systematic literature review and meta-analysisMichael J Carter
University of Nebraska Medical Center, 986270 Nebraska Medical Center, Omaha, NE 68198 6270, USA
J Bone Joint Surg Am 94:e127. 2012..The goal of this systematic review and meta-analysis was to characterize the change in generic and shoulder-specific health-related quality-of-life measures resulting from total shoulder arthroplasty...
Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effectsChristopher J Smith
Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 6270, USA
Arthritis Res Ther 13:R168. 2011..We characterize the use of minocycline and doxycycline in community-dwelling RA patients by examining associated prescribing patterns, patient-level determinants of use, and side-effect profiles...
Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patientsKaleb Michaud
University of Nebraska Medical Center, Omaha, 68198 6270, USA
Arthritis Care Res (Hoboken) 63:366-72. 2011..To examine predictors of progression of disability in rheumatoid arthritis (RA), as measured by the Health Assessment Questionnaire disability index (HAQ), and to determine rates of progression during biologic treatment...
Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional studyTed R Mikuls
Omaha Veterans Affairs Medical Center and Nebraska Arthritis Outcomes Research Center, University of Nebraska Medical Center, 986270 Nebraska Medical Center, Omaha, NE 68198 6270, USA
Arthritis Res Ther 12:R213. 2010..The purpose of this study was to examine the associations of GSTM1-null with ACPA positivity in RA and to assess for evidence of interaction between GSTM1 and HLA-DRB1 shared epitope (SE)...
The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational studyFrederick Wolfe
National Data Bank for Rheumatic Diseases, 1035 N, Emporia, Suite 288, Wichita, KS 67214, USA
Arthritis Res Ther 12:R35. 2010..We modeled the progression of loss of health status, and measured incremental costs and effectiveness of biologic therapy in the community...
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseasesSherine E Gabriel
Department of Health Sciences Research, Mayo Foundation, Rochester, MN 55905, USA
Arthritis Res Ther 11:229. 2009..Taken together, these findings underscore the complexity of the rheumatic diseases and highlight the key role of epidemiological research in understanding these intriguing conditions...
Quality of life in patients with rheumatoid arthritis: does abatacept make a difference?K Michaud
Section of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198 6270, USA
Clin Exp Rheumatol 25:S35-45. 2007..Analysis of these data demonstrates that abatacept therapy has the potential to improve QoL across a range of patients with RA...
Poor to modest agreement between rheumatoid arthritis response measures in clinical practiceK Michaud
VA Medical Center and Nebraska Arthritis Outcomes Research Center, University of Nebraska Medical Center, Omaha, Nebraska, USA
Clin Exp Rheumatol 27:633-40. 2009..To evaluate the agreement among several rheumatoid arthritis (RA) response measures in a clinical setting...
Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritisKaleb Michaud
University of Nebraska Medical Center, Omaha, Nebraska, USA
J Rheumatol 39:54-9. 2012....
Comorbidities in rheumatoid arthritisKaleb Michaud
University of Nebraska Medical Center, Omaha, Nebraska 68198 6270, USA
Best Pract Res Clin Rheumatol 21:885-906. 2007..This chapter reviews important comorbidities in patients with RA, their prevalence, and their relation to RA...
Rheumatoid arthritis treatment and the risk of severe interstitial lung diseaseF Wolfe
National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Wichita, KS 67214, USA
Scand J Rheumatol 36:172-8. 2007..Reports have suggested that infliximab with or without azathioprine might lead to rapidly progressive or fatal ILD. We used an RA data bank to assess the associations of treatments for RA and severe ILD...
Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectivenessF Wolfe
National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Wichita, KS 67214, USA
Rheumatology (Oxford) 44:iv18-iv22. 2005..The consequence of deriving effectiveness estimates from clinical trials is to overestimate the effectiveness and thereby the cost-effectiveness of rheumatoid arthritis treatments...
Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapyFrederick Wolfe
National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Wichita, Kansas 67214, USA
J Rheumatol 34:1674-83. 2007....
Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitorsEliza F Chakravarty
Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA
J Rheumatol 32:2130-5. 2005..173, respectively). CONCLUSION: In this large, national cohort, RA was associated with an increased risk for development of NMSC. Among patients with RA, use of TNF inhibitors and prednisone were associated with an increased risk of NMSC...
The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observationFrederick Wolfe
National Data Bank for Rheumatic Diseases, Wichita, KS 67214, USA
Arthritis Rheum 56:1433-9. 2007..This report updates our previous report during 29,314 person-years of followup...
Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgiaFrederick Wolfe
National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
J Rheumatol 31:695-700. 2004..Little is known about FM among patients with rheumatoid arthritis (RAF). We used the survey definition to characterize persons with RAF and to obtain insight into possible pathogenic mechanisms...
Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patientsFrederick Wolfe
National Data Bank for Rheumatic Diseases, Arthritis Research Foundation, Wichita, KS 67214, USA
Arthritis Rheum 50:1740-51. 2004..Additionally, we sought to determine predictors of lymphoma in RA...
Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control studyZurab Nadareishvili
Georgetown University Hospital, Washington, DC, USA
Arthritis Rheum 59:1090-6. 2008..To determine the risk of stroke in patients with rheumatoid arthritis (RA) and risk factors associated with stroke...
The association of rheumatoid arthritis and its treatment with sinus diseaseKaleb Michaud
National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
J Rheumatol 33:2412-5. 2006..Slight protective effects on sinus problems are noted with sulfasalazine and leflunomide, and a slight increase in risk of sinus problems is noted with etanercept...
Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomesLiron Caplan
University of Colorado at Denver and Health Science Center, Denver, USA
J Rheumatol 34:696-705. 2007....
Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysisAllan J Wailoo
Health Economics and Decision Science, ScHARR, University of Sheffield, Sheffield, UK
Arthritis Rheum 58:939-46. 2008..We undertook to develop a model to compare the costs and quality-adjusted life years (QALYs) generated by each of the 4 biologic agents...
Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choicesFrederick Wolfe
National Data Bank for Rheumatic Diseases, Wichita, Kansas 67214, USA
Arthritis Rheum 56:2135-42. 2007..This study was undertaken to investigate patients' acceptance and satisfaction with therapy, willingness to change therapy, and reasons for not changing...
The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitorsElizabeth Benito-Garcia
Department of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, Boston, Massachusetts, USA
J Rheumatol 34:1765-9. 2007....
Predicting mortality in patients with rheumatoid arthritisFrederick Wolfe
Arthritis Research Center Foundation and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
Arthritis Rheum 48:1530-42. 2003..This study was undertaken to evaluate the relative predictive strength and usefulness of a wide range of variables on the risk of mortality in a large, long-term, prospectively studied cohort of patients with RA...
The challenges of determining RA disease activity and remission in clinical practiceFrederick Wolfe
National Data Bank for Rheumatic Diseases, and University of Kansas School of Medicine, Wichita, KS 67214, USA
Nat Clin Pract Rheumatol 4:462-3. 2008
Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritisFrederick Wolfe
National Data Bank for Rheumatic Diseases, Wichita, Kansas 67214, USA
Arthritis Rheum 57:935-42. 2007....
Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational studyFrederick Wolfe
National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS 67214, USA
Arthritis Rheum 56:2886-95. 2007..We undertook this study to assess the risk of malignancy among biologic-treated patients in a large US observational database...
The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disabilityFrederick Wolfe
National Data Bank for Rheumatic Diseases, 1035 N Emporia, Wichita, KS 67214, USA
J Rheumatol 34:2211-7. 2007..To determine the prevalence and incidence rates of work disability in rheumatoid arthritis (RA), and to determine the effect of anti-tumor necrosis factor (TNF) therapy on work disability...
Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scalesFrederick Wolfe
National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
J Rheumatol 33:1942-51. 2006..SD has taken on new importance with the observation that etanercept and infliximab reduce daytime sleepiness, and patient groups indicate that sleep is an important issue...
Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritisFrederick Wolfe
Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, KS 67214, USA
J Rheumatol 32:1261-6. 2005....
Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patientsNancy Walker
Rheumatology Division, Department of Medicine, University of Massachusetts, Worcester, Massachusett, USA
J Rheumatol 32:1006-12. 2005..Whether this information will have greater predictive ability and clinical relevance compared with surrogate measures such as the HAQ and SF-36 has not been determined, but should be the subject of future studies...
Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritisFrederick Wolfe
Arthritis Research Center Foundation and the University of Kansas School of Medicine, Wichita, Kansas 67214, USA
J Rheumatol 32:583-9. 2005..To define RID, we compared mean and/or least desirable clinical states with best and/or most desirable states...
Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new modelFrederick Wolfe
J Rheumatol 31:2317-9. 2004
Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patientsFrederick Wolfe
Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
J Rheumatol 31:2115-20. 2004..We evaluate the importance of fatigue in relation to other measures of clinical status, describe predictors of fatigue, and investigate fatigue levels in patients treated with anti-TNF therapy...
Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapyFrederick Wolfe
Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita 67214, USA
Am J Med 116:305-11. 2004..We sought to determine the frequency of heart failure in patients with rheumatoid arthritis, and to determine its predictors, particularly the use of anti-tumor necrosis factor (TNF) therapy...
Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapyFrederick Wolfe
National Data Bank for Rheumatic Diseases, Wichita, Kansas, and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
Arthritis Rheum 50:372-9. 2004..We undertook this study to determine the baseline rate of TB in RA prior to the introduction of infliximab and to determine the rate of TB among those currently receiving infliximab...
Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practiceFrederick Wolfe
National Data Bank for Rheumatic Diseases Arthritis Research Center Foundation, Wichita, Kansas 67214, USA
J Rheumatol 31:355-8. 2004..To compare COX-2-specific inhibitor therapy with conventional nonspecific nonsteroidal antiinflammatory drugs (NS NSAID), and investigate the effect of demographic and disease factors on NSAID duration of use...
Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patientsKaleb Michaud
Arthritis Research Center Foundation, Wichita, Kansas, USA
Arthritis Rheum 48:2750-62. 2003..RA patients with poor function continue to incur substantially higher costs, as do those with comorbid conditions, and sociodemographic characteristics also play an important role in determination of costs...
Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritisSaralynn Allaire
Boston University, Boston, Massachusetts, USA
Arthritis Rheum 53:603-8. 2005..To examine the extent and financial impact of work disability among older workers with rheumatoid arthritis (RA)...
Household income and earnings losses among 6,396 persons with rheumatoid arthritisFrederick Wolfe
Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, KS 67214, USA
J Rheumatol 32:1875-83. 2005..We describe methods for obtaining earnings and household income losses that are applicable to working as well as nonworking RA patients, and we perform such studies using these methods...
Can severity be predicted by treatment variables in rheumatoid arthritis administrative data bases?Frederick Wolfe
National Data Bank for Rheumatic Diseases, and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
J Rheumatol 33:1952-6. 2006..We examined whether treatment variables could predict RA severity...
Anemia and renal function in patients with rheumatoid arthritisFrederick Wolfe
National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, 67214, USA
J Rheumatol 33:1516-22. 2006..Despite recognition that anemia is common in RA and that renal function may be impaired and affect hemoglobin levels, there are almost no quantitative comparative data regarding the prevalence of anemia or decreased renal function in RA...
Extent of occupational hand use among persons with rheumatoid arthritisSaralynn Allaire
Clinical epidemiology Research and Training Unit A203, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA
Arthritis Rheum 55:294-9. 2006....
Gastrointestinal prophylactic therapy among patients with arthritis treated by rheumatology specialistsElizabeth Benito Garcia
Brigham and Women's Hospital, Boston, Massachusetts, USA
J Rheumatol 33:779-84. 2006..The major determinant of GPA use appears to be physician prescribing behavior...
Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapyFrederick Wolfe
National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
Arthritis Rheum 54:628-34. 2006..This study was undertaken to determine the rate and predictors of hospitalization for pneumonia and the extent to which specific RA treatments increase pneumonia risk...
Jaw pain: its prevalence and meaning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgiaFrederick Wolfe
National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
J Rheumatol 32:2421-8. 2005..We investigated the prevalence and correlates of jaw pain, and whether jaw pain is increased in RA, where intrinsic articular disease can be noted radiographically, or is a manifestation of a generalized pain problem...
A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II)Frederick Wolfe
National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
J Rheumatol 32:2410-5. 2005..To develop and validate a composite patient self-report disease activity scale for use in clinical practice and in observational studies and clinical trials...
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposesFrederick Wolfe
National Data Bank for Rheumatic Diseases, Wichita, Kansas 67214, USA
Arthritis Rheum 52:3873-9. 2005....
Minimal disease activity for rheumatoid arthritis: a preliminary definitionGeorge A Wells
Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada
J Rheumatol 32:2016-24. 2005..This set of 2 definitions gained approval of 73% of the attendees. These (and other) definitions will now be subject to further validation in other databases...
Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexateFrederick Wolfe
National Data Bank for Rheumatic Diseases, Wichita, Kansas, USA
J Rheumatol 30:1725-32. 2003..In addition, (4) we test the feasibility of performing a clinical trial using a longitudinal data bank...
